News

The result could reshape Moderna's post-vaccine growth story

Estee Lauder (EL) shares rallied Wednesday after the cosmetics maker bumped up its fiscal 2027 opera

Wedbush sees another sign of memory inflation.

Bitcoin broke above $68,000 Wednesday, lifting shares of many crypto stocks as digital-currency leaders are scheduled to meet with President Trump in the White House this afternoon. The largest cryptocurrency gained about 6% and recently traded around $68,500, its largest percentage increase since March.

Industrial stocks have gotten expensive, but here are some with the most attractive growth prospects.

Bitcoin is surging, tokenized stocks are breaking records, and two retail brokerages are racing to claim the next era of American finance before regulators decide who gets left behind.

EL beats fiscal fourth-quarter estimates as sales rise 6%, fueled by Skin Care and Fragrance growth and sharply higher operating income.

Cogent Communications' 14% weekly rebound follows a narrower Q2 loss and margin gains, but revenue declines, Sprint runoff and debt risks keep the setup mixed.

Bitcoin broke out of a months long trading range, surging as much as 7.7%, amid optimism on the regulatory front with industry officials gathering at the White House.

On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock's biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.'s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. - Shares of Estee Lauder (EL) rallied after the beauty company's adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views. - Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker's forecast sales for the second quarter missed the average analyst estimate.

Moderna shares more than doubled Wednesday after it announced initial results from a study of an experimental cancer treatment that would be the first of its kind if approved by regulators. Moderna and Merck are developing a treatment using an mRNA-based cancer vaccine called intismeran that is designed to be tailored to individual patients based on unique mutations within their tumors. In current studies, they are pairing it with Keytruda, a immunotherapy drug made by Merck.

TGT tops Q2 estimates as traffic, digital and category sales strengthen, while tariff refunds lift profitability, and management raises its fiscal 2026 outlook.

Comparable sales rose 3.8% on traffic growth, with EPS guidance lifted $0.75 excluding tariff refunds

Eshallgo’s California subsidiary will exclusively distribute Zhongshan Senwei printing consumables in North America, initially targeting major e-commerce channels as the company builds its overseas operations. Key Investor TakeawaysEshallgo (NASDAQ:EHGO) has secured an exclusive North American distribution partnership with Chinese printing consumables manufacturer Zhongshan Senwei.

Estee Lauder Companies Inc (NYSE:EL, XETRA:ELAA) shares jumped more than 15% on Wednesday after the beauty group posted fourth-quarter results that beat Wall Street estimates and raised its profit margin outlook for fiscal 2027. The company reported revenue of $3.6 billion for its fiscal...

Unitree builds AI-powered robots that rival Tesla's Optimus units. Unitree raised more than $900 million with its IPO.

TJX Companies Inc (NYSE:TJX) reported second-quarter profit and revenue above Wall Street estimates on Wednesday, as the off-price retailer's discount model continued to draw shoppers, though shares fell 1.3% at the open. The parent of TJ Maxx, Marshalls and HomeGoods posted adjusted earnings...

Marvell Technology stock jumped after the chipmaker announced a deal to develop chips for Alphabet unit Google.

By Julie Steenhuysen and Christy Santhosh CHICAGO, Aug 19 (Reuters) - Moderna's personalized mRNA cancer therapy, developed with Merck, reduced the risk of melanoma recurrence and spread in a late-

Target Corp (NYSE:TGT) has raised its full-year outlook after reporting stronger-than-expected second quarter results. For the quarter, sales were up 5.3% year-over-year at $26.54 billion, ahead of Wall Street estimates of $26.13 billion. Comparable sales increased 3.8% year over year, while...

Shares of Estée Lauder advanced on Wednesday as the beauty and cosmetics giant’s better-than-expected quarterly earnings showed Wall Street its growth plan is well underway. The company announced adjusted earnings of 39 cents a share in the fiscal fourth quarter, up from 9 cents a year ago and above Wall Street’s expectation of 32 cents. Estée Lauder reported adjusted earnings of $2.51 a share for the full fiscal year, up from $1.51 last year.

Marti Technologies, Inc. (AMEX:MRT) shares gained 5% in pre-market trading on Wednesday after the Turkish mobility super app delivered second-quarter revenue well above expectations and raised its full-year outlook, despite reporting a wider-than-expected adjusted loss per share.

The cosmetics company forecast fiscal 2027 adjusted EPS of $3.10 to $3.35, with the midpoint above analyst estimates

Marvell Technology said on Wednesday it has issued ‌Alphabet's Google a warrant to ‌buy a stake worth about $12.18 billion as ​part of a deal to help develop custom chips for the search giant. Shares of the custom chipmaker jumped ‌more than ⁠11% in premarket trading, while larger rival Broadcom was ⁠down over 3%. Demand for custom chips such as Google's tensor processing units (TPUs), ​used for ​AI workloads, ​has surged in ‌recent years as businesses seek alternatives to Nvidia's pricey graphics processors.

The chipmaker's revenue jumped 40% to $4.02 billion in its fiscal third quarter, beating analyst expectations of $3.92 billion

If humanoid robots are the future, then Elon Musk faces a formidable Chinese rival. China’s Unitree Robotics surged 460% on its trading debut in Shanghai Wednesday, giving the company a market capitalization of around $51 billion. Robots, of course, have been around for decades.

Target now expects full-year net sales growth in a range around 5%, one percentage point higher than the prior guidance range.

By Vibhuti Sharma Aug 19 (Reuters) - Global investment firm KKR will buy a stake of about 6% in Indian ticketing and entertainment platform BookMyShow for $40 million to $50 million, a source told

Analog Devices forecast fourth-quarter revenue and profit above Wall Street estimates on ‌Wednesday, betting on continued demand for its power-management ‌chips used across data centers and industrial applications as AI ​investments ramp up. The company stands to benefit from surging investment in AI-driven computing, which has boosted demand for chips that regulate power and move vast amounts of ‌data. Its components ⁠are widely used in data centers, factory automation equipment and modern vehicles.

Shares of US vaccine-maker Moderna soared 60 per cent in pre-market trading after the company reported successful results for a melanoma cancer...